nodes	percent_of_prediction	percent_of_DWPC	metapath
SIMEPREVIR—CYP3A4—bone cancer	0.74	1	CbGaD
SIMEPREVIR—SLCO1B1—Methotrexate—bone cancer	0.0744	0.364	CbGbCtD
SIMEPREVIR—ALB—Methotrexate—bone cancer	0.0408	0.199	CbGbCtD
SIMEPREVIR—ABCB1—Cisplatin—bone cancer	0.0328	0.161	CbGbCtD
SIMEPREVIR—ABCB1—Doxorubicin—bone cancer	0.022	0.108	CbGbCtD
SIMEPREVIR—ABCB1—Methotrexate—bone cancer	0.0213	0.104	CbGbCtD
SIMEPREVIR—CYP3A4—Doxorubicin—bone cancer	0.0132	0.0645	CbGbCtD
SIMEPREVIR—CTSS—Collagen formation—PLOD2—bone cancer	0.00419	0.0757	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00337	0.0608	CbGpPWpGaD
SIMEPREVIR—CTSS—Assembly of collagen fibrils and other multimeric structures—LOX—bone cancer	0.00304	0.0549	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00278	0.0502	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.0026	0.047	CbGpPWpGaD
SIMEPREVIR—CTSS—Collagen formation—LOX—bone cancer	0.00207	0.0374	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Irinotecan Pathway—CYP3A4—bone cancer	0.00178	0.0321	CbGpPWpGaD
SIMEPREVIR—CTSS—Extracellular matrix organization—PLOD2—bone cancer	0.00168	0.0303	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00152	0.0275	CbGpPWpGaD
SIMEPREVIR—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00139	0.0251	CbGpPWpGaD
SIMEPREVIR—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.0013	0.0235	CbGpPWpGaD
SIMEPREVIR—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.0013	0.0235	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—FOLR1—bone cancer	0.00126	0.0228	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.00124	0.0223	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00111	0.02	CbGpPWpGaD
SIMEPREVIR—CTSS—Toll-Like Receptors Cascades—ATF1—bone cancer	0.000872	0.0157	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000853	0.0154	CbGpPWpGaD
SIMEPREVIR—CTSS—Extracellular matrix organization—LOX—bone cancer	0.000828	0.015	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000803	0.0145	CbGpPWpGaD
SIMEPREVIR—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000761	0.0137	CbGpPWpGaD
SIMEPREVIR—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000748	0.0135	CbGpPWpGaD
SIMEPREVIR—CTSS—Assembly of collagen fibrils and other multimeric structures—MMP9—bone cancer	0.000734	0.0133	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000638	0.0115	CbGpPWpGaD
SIMEPREVIR—CTSS—Degradation of the extracellular matrix—MMP2—bone cancer	0.000635	0.0115	CbGpPWpGaD
SIMEPREVIR—CTSS—Extracellular matrix organization—SPARC—bone cancer	0.000621	0.0112	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000597	0.0108	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.00058	0.0105	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000556	0.01	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000533	0.00964	CbGpPWpGaD
SIMEPREVIR—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—bone cancer	0.000518	0.00936	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000513	0.00927	CbGpPWpGaD
SIMEPREVIR—CTSS—Collagen formation—MMP9—bone cancer	0.0005	0.00903	CbGpPWpGaD
SIMEPREVIR—CTSS—Degradation of the extracellular matrix—MMP9—bone cancer	0.000477	0.00862	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000476	0.00859	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000461	0.00833	CbGpPWpGaD
SIMEPREVIR—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000459	0.00829	CbGpPWpGaD
SIMEPREVIR—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000437	0.0079	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000367	0.00663	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000349	0.0063	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—DHFR—bone cancer	0.000346	0.00626	CbGpPWpGaD
SIMEPREVIR—CTSS—Toll-Like Receptors Cascades—JUN—bone cancer	0.00034	0.00613	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet degranulation—SPARC—bone cancer	0.000303	0.00548	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000301	0.00543	CbGpPWpGaD
SIMEPREVIR—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000289	0.00522	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—ATF1—bone cancer	0.000282	0.0051	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000274	0.00495	CbGpPWpGaD
SIMEPREVIR—CTSS—Extracellular matrix organization—MMP2—bone cancer	0.000266	0.00481	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000222	0.004	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000219	0.00395	CbGpPWpGaD
SIMEPREVIR—CTSS—Extracellular matrix organization—MMP9—bone cancer	0.0002	0.00361	CbGpPWpGaD
SIMEPREVIR—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.00019	0.00344	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000183	0.00331	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00018	0.00324	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—ATF1—bone cancer	0.000164	0.00297	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—KIT—bone cancer	0.000161	0.0029	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—IL3—bone cancer	0.00016	0.0029	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000158	0.00285	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000156	0.00282	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—KIT—bone cancer	0.000154	0.00279	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000148	0.00267	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—NDUFA12—bone cancer	0.000143	0.00258	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000139	0.00252	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.000135	0.00243	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000133	0.00239	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—MDM2—bone cancer	0.000127	0.00229	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000126	0.00228	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.000123	0.00222	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—MDM2—bone cancer	0.000122	0.0022	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000121	0.00219	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000121	0.00218	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—NT5C3A—bone cancer	0.000119	0.00214	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	0.000114	0.00205	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000112	0.00202	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—JUN—bone cancer	0.00011	0.00199	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.00011	0.00199	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000109	0.00198	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000108	0.00196	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000105	0.00189	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	0.000103	0.00187	CbGpPWpGaD
SIMEPREVIR—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	0.000103	0.00186	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	9.72e-05	0.00176	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Biological oxidations—CYP3A4—bone cancer	9.54e-05	0.00172	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	9.41e-05	0.0017	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—KIT—bone cancer	9.36e-05	0.00169	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	9.19e-05	0.00166	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	9.16e-05	0.00166	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.03e-05	0.00163	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—EGFR—bone cancer	8.65e-05	0.00156	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	8.61e-05	0.00155	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	8.61e-05	0.00155	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—EGFR—bone cancer	8.3e-05	0.0015	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NDUFA12—bone cancer	8.17e-05	0.00148	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Biological oxidations—GSTP1—bone cancer	8.16e-05	0.00147	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	8.05e-05	0.00145	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.91e-05	0.00143	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—TP53—bone cancer	7.74e-05	0.0014	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—MDM2—bone cancer	7.37e-05	0.00133	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NDUFA12—bone cancer	7.16e-05	0.00129	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—SPARC—bone cancer	6.94e-05	0.00125	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	6.81e-05	0.00123	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NT5C3A—bone cancer	6.77e-05	0.00122	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—JUN—bone cancer	6.41e-05	0.00116	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—GNA11—bone cancer	6.34e-05	0.00115	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Biological oxidations—GSTP1—bone cancer	6.3e-05	0.00114	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	6.21e-05	0.00112	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NT5C3A—bone cancer	5.93e-05	0.00107	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—IL3—bone cancer	5.75e-05	0.00104	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NDUFA12—bone cancer	5.72e-05	0.00103	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—ENO2—bone cancer	5.19e-05	0.000938	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	5.05e-05	0.000912	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—EGFR—bone cancer	5.04e-05	0.00091	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.87e-05	0.00088	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—DHFR—bone cancer	4.82e-05	0.00087	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NT5C3A—bone cancer	4.74e-05	0.000856	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—GNA11—bone cancer	4.5e-05	0.000813	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NDUFA12—bone cancer	4.41e-05	0.000797	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4.39e-05	0.000793	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CYP3A4—bone cancer	4.08e-05	0.000737	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.06e-05	0.000734	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PLAU—bone cancer	3.77e-05	0.000682	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NT5C3A—bone cancer	3.66e-05	0.000661	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—GSTP1—bone cancer	3.49e-05	0.000631	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.45e-05	0.000624	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ENO2—bone cancer	2.97e-05	0.000536	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.9e-05	0.000524	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—DHFR—bone cancer	2.75e-05	0.000497	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ENO2—bone cancer	2.6e-05	0.00047	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GNA11—bone cancer	2.57e-05	0.000465	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—DHFR—bone cancer	2.41e-05	0.000436	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYP3A4—bone cancer	2.33e-05	0.000421	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.32e-05	0.000419	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GNA11—bone cancer	2.25e-05	0.000407	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ENO2—bone cancer	2.08e-05	0.000375	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP3A4—bone cancer	2.04e-05	0.000369	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTP1—bone cancer	1.99e-05	0.00036	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—DHFR—bone cancer	1.93e-05	0.000348	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PTGS2—bone cancer	1.81e-05	0.000327	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GNA11—bone cancer	1.8e-05	0.000325	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTP1—bone cancer	1.75e-05	0.000316	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP3A4—bone cancer	1.63e-05	0.000295	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.62e-05	0.000293	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ENO2—bone cancer	1.6e-05	0.000289	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—TP53—bone cancer	1.52e-05	0.000274	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—DHFR—bone cancer	1.49e-05	0.000268	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTP1—bone cancer	1.4e-05	0.000252	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GNA11—bone cancer	1.39e-05	0.000251	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTP1—bone cancer	1.08e-05	0.000195	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PTGS2—bone cancer	1.03e-05	0.000187	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PTGS2—bone cancer	9.05e-06	0.000164	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PTGS2—bone cancer	7.23e-06	0.000131	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PTGS2—bone cancer	5.58e-06	0.000101	CbGpPWpGaD
